Shantha Biotechnics
| Industry | Biotechnology, Vaccines |
|---|---|
| Founded | 1993 |
| Founder | K. I. Varaprasad Reddy |
| Headquarters | Medchal, Hyderabad (India) |
Key people |
K. I. Varaprasad Reddy (Chairman) Harish Iyer (CEO) |
| Products | recombinant DNA vaccines |
| Parent | Sanofi |
| Slogan | Health Care People |
| Website | Shanthabiotech.com |
Shantha Biotechnics is an Indian biotechnology company based in Hyderabad. It is the first Indian company to develop, manufacture and market recombinant human healthcare products in India. The company is a wholly owned subsidiary of Sanofi group.[1]
History
The genesis of Shantha Biotechnics, Ltd. can be traced back to the initiatives of Dr. K I Varaprasad Reddy and Khalil Ahmed. Varaprasad and Ahmed established the company in 1993 to produce cost-effective drugs to reach the common man at an affordable price, while maintaining International standards in quality.[1] The project originated as an R&D outfit at the Osmania University under the industry-university interactive programme in 1993, and later operated out of the Center for Cellular and Molecular Biology until an independent R&D facility was built.
In 2006, the European biotech major Mérieux Alliance bought 60% stake in Shantha Biotechnics at a valuation of $175 million. [2]
In 2009, the vaccine division of French pharmacological company Sanofi Pasteur acquired the stake held by Mérieux Alliance, valuing Shantha Biotech at Euro 550 million (over Rs 3,770 crore).[3]
Over time, Sanofi acquired further stake in Shantha Biotechnics and in 2013, acquired 100% of the company. [4]
Products
Drugs developed by Shantha include SHANVAC-B, SHANFERON, SHANKINASE, SHANPOIETIN, SHANTETRA, SHAN5, SHAN HIB-DPT, SHAN HIB, and SHANTT.
Today, Shantha Biotechnics caters to major international markets including Asia-Pacific, Africa, CIS and Latin America in addition to international organisations like UNICEF and PAHO.
Insuman Cartridges Project
CM K.Chandrashekar Rao (KCR) laid stone foundation for Insuman Cartridges project in Medak district.[5] This project will be executed by Shantha Biotechnics Private limited.
The Main object of the insuman cartridges Project is to produce Insulin at a lower cost and located at Medak district Telangana state.The Project Cost for 460 crore.[6]
See also
References
- 1 2 "Shantha Biotech to launch 5-in-1 pediatric vaccine - CNBC-TV18". Moneycontrol.com. Retrieved 2012-09-28.
- ↑ "Sanofi-Aventis Takes Control Of Shantha Biotechnics". VCCircle. Retrieved 2015-09-19.
- ↑ Somashekar Mulugu. "Business Line : Companies News : Top level changes at Shantha Biotechnics". Thehindubusinessline.com. Retrieved 2012-09-28.
- ↑ "Sanofi infusing $122M to complete buy-out of Shantha Biotech and further expansion". VCCircle. Retrieved 2015-09-19.
- ↑ Details: CM KCR lays foundation stone for Insuman Cartridges project in Medak
- ↑ Details: Insuman Cartridges Project
External links
- Sanofi Pasteur homepage.
- Shantha Biotechnics Insuman Cartridges project in Medak district.
- Telangana State: insuman cartridges Project
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||